CIP 108297T
Mycobacteroides abscessus massiliense
CCUG 48898;KCTC 19086;DSM 45103
CIP
Bacteria
yes
France
Marseille
01-01-2001
37 °C
Aerobic
J. Clin. Microbiol, 2004, 42, 5493, doi:10.1128/JCM.42.12.5493-5501.2004; Int. J. Syst. Evol. Microbiol, 2006, 56, 2025, doi:10.1099/ijs.0.64643-0; Int. J. Syst. Evol. Microbiol, 2011, 61, 2311, doi:10.1099/ijs.0.023770-0; Int. J. Syst. Evol. Microbiol, 2011, 61, 2797, doi:10.1099/ijs.0.038521-0; PLoS One, 2011, 6(9), e24726, pmid:21931831; J. Clin. Microbiol, 2011, 49(2), 491, pmid:21106786; J. Clin. Microbiol., 2011, 49(1), 62-68; J. Clin. Microbiol, 2011, 49(3), 1107, pmid:21177894; J. Bacteriol, 2012, 194, 4125, doi:10.1128/JB.00712-12; Antimicrob. Agents Chemother, 2011, 55(2), 775, pmid:21135185; Int. J. Syst. Evol. Microbiol, 2016, 66, 4471, doi:10.1099/ijsem.0.001376; Int. J. Syst. Evol. Microbiol, 2017, 67, 179, doi:10.1099/ijsem.0.001766; Int. J. Syst. Evol. Microbiol, 2017, 67, 2726, doi:10.1099/ijsem.0.002011; Front. Microbiol, 2018, 9, 67, doi:10.3389/fmicb.2018.00067; Int. J. Syst. Evol. Microbiol, 2018, 68, 1411, doi:10.1099/ijsem.0.002711
2
2004, M. Drancourt, Timone Hosp., Marseille, France: strain LB, Mycobacterium massiliense
Sputum
Produces acetoin Degrades gelatin

Risk group: 2 (classification according to CIP)

B
Processing
processing in progress, please wait...